{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:00Z","timestamp":1790298600631,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejca.2026.116706","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:13:22Z","timestamp":1774714402000},"page":"116706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO"],"prefix":"10.1016","volume":"239","author":[{"given":"Emeric","family":"Boisteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Boil\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-9635","authenticated-orcid":false,"given":"David","family":"Tougeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"De Malet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5093-0212","authenticated-orcid":false,"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8834-6927","authenticated-orcid":false,"given":"Thomas","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-585X","authenticated-orcid":false,"given":"Simon","family":"Pernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1222-7778","authenticated-orcid":false,"given":"Julien","family":"Pinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-4830","authenticated-orcid":false,"given":"Anna","family":"Pellat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-6448","authenticated-orcid":false,"given":"Vincent","family":"Hautefeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-3938","authenticated-orcid":false,"given":"Nadim","family":"Far\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Desgrippes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-8340","authenticated-orcid":false,"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-5653","authenticated-orcid":false,"given":"Aziz","family":"Zaanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-7741","authenticated-orcid":false,"given":"Julien","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Philonenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-0423","authenticated-orcid":false,"given":"Olivier","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-0101","authenticated-orcid":false,"given":"Anthony","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116706_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dld.2017.09.123","article-title":"Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"50","author":"Locher","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejca.2026.116706_bib2","unstructured":"Noone A.M.M.D. 2018. n.d."},{"key":"10.1016\/j.ejca.2026.116706_bib3","article-title":"Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort study","volume":"199","author":"de Back","year":"2024","journal-title":"Eur J Cancer 1990"},{"key":"10.1016\/j.ejca.2026.116706_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.32860","article-title":"Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients","volume":"147","author":"Aparicio","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib5","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/cncr.23822","article-title":"Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma","volume":"113","author":"Overman","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib6","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdq038","article-title":"Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study","volume":"21","author":"Zaanan","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib7","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","article-title":"Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater","volume":"27","author":"Overman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.6004\/jnccn.2019.0043","article-title":"Small Bowel Adenocarcinoma, Version 1.2020","volume":"17","author":"Benson","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejca.2026.116706_bib9","first-page":"78","article-title":"Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma","volume":"16","author":"Aydin","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00280-017-3371-0","article-title":"Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer","volume":"80","author":"Takayoshi","year":"2017","journal-title":"Cancer Chemother Pharm"},{"key":"10.1016\/j.ejca.2026.116706_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1634\/theoncologist.2017-0568","article-title":"Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater","volume":"23","author":"Gulhati","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2026.116706_bib12","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/bjc.2013.677","article-title":"Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study","volume":"109","author":"Aparicio","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.14694\/EdBook_AM.2013.33.189","article-title":"Rare but Real: Management of Small Bowel Adenocarcinoma","author":"Overman","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejca.2026.116706_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1186\/s12885-021-08724-5","article-title":"Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma","volume":"21","author":"Amano","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cncr.30445","article-title":"Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study","volume":"123","author":"Gulhati","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11523-019-00681-1","article-title":"Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study","volume":"14","author":"Legu\u00e9","year":"2019","journal-title":"Target Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib18","unstructured":"Ad\u00e9nocarcinome de l\u2019intestin gr\u00eale | SNFGE 2024. https:\/\/www.snfge.org\/tncd\/adenocarcinome-lintestin-grele (accessed April 12, 2025)."},{"key":"10.1016\/j.ejca.2026.116706_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009672","article-title":"Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma","volume":"97","author":"Falcone","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.ejca.2026.116706_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6605898","article-title":"Cetuximab in small bowel adenocarcinoma: a new friend?","volume":"103","author":"Santini","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/gut.2009.196428","article-title":"Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma","volume":"59","author":"De Dosso","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2026.116706_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49179-w","article-title":"The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma","volume":"9","author":"Zimmermann","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2026.116706_bib24","first-page":"78","article-title":"Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma","volume":"16","author":"Aydin","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jss.2020.03.017","article-title":"Small Bowel Adenocarcinomas: Impact of Location on Survival","volume":"252","author":"Lee","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejca.2026.116706_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.35379","article-title":"Survival outcomes in small intestine tumors: The role of duodenum, jejunum, and ileum","volume":"157","author":"Wu","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","article-title":"A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease","volume":"19","author":"Overman","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib28","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116706_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair\u2013Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.32860","article-title":"Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients","volume":"147","author":"Aparicio","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116706_bib32","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015381","article-title":"Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis","volume":"98","author":"Tian","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ejca.2026.116706_bib34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jso.70090","article-title":"Peritoneal Metastases in Gastrointestinal Malignancies: A Review of the Pathophysiology of Metastasis and the Tumour Microenvironment","volume":"132","author":"Patel","year":"2025","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116706_bib35","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.dld.2025.07.018","article-title":"FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trial","volume":"57","author":"Aparicio","year":"2025","journal-title":"Dig Liver Dis"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926004867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926004867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:10:22Z","timestamp":1777623022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926004867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"alternative-id":["S0959804926004867"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116706","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116706"}}